首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

臨床試驗用品及耗材市場規模、佔有率及成長分析（按服務、階段、類型、治療領域及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900254

臨床試驗用品及耗材市場規模、佔有率及成長分析（按服務、階段、類型、治療領域及地區分類）－2026-2033年產業預測

Clinical Trial Materials And Supplies Market Size, Share, and Growth Analysis, By Service (Logistics & Distribution, Storage & Retention), By Phase, By Type, By Therapeutic Area, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球臨床試驗用品和耗材市場預計到 2024 年將達到 38.4 億美元，到 2025 年將達到 42.2 億美元，到 2033 年將達到 89.1 億美元，預測期（2026-2033 年）的複合年成長率為 9.8%。

臨床試驗耗材管理至關重要，尤其是在藥物研發成本不斷上漲的情況下，它可以避免庫存過期和生產過剩等問題。高效的供應鏈對於應對複雜的臨床研究並遵守監管要求至關重要。臨床試驗耗材市場的成長動力源自於臨床研究數量的增加和複雜性的增加。耗材涵蓋了醫療試驗所需的各種設備，例如輸液幫浦、霧化器和注射針，這些設備用於疾病的診斷和治療、治療方法評估以及支援各種醫療程序。隨著藥物研發企業將臨床試驗耗材外包給研究機構，在技術進步、供應商之間的策略合作以及專利到期等因素的推動下，該市場正經歷加速成長。

全球臨床試驗用品和耗材市場促進因素

全球臨床試驗用品和耗材市場的擴張主要得益於中國、印度和韓國等新興國家患者參與臨床試驗的動機不斷提高。與已開發國家相比，這些國家的成本顯著降低。這些地區能夠以更低的成本進行早期臨床試驗，從而為研究，特別是罕見疾病研究，創造了極具吸引力的環境。此外，技術和數據分析的進步在簡化臨床試驗流程方面發揮關鍵作用，促使製藥和生物技術公司尋求創新解決方案。這種在發展中國家進行臨床試驗的趨勢提高了效率，並促進了產業內的合作。

全球臨床試驗用品和耗材市場面臨的限制因素

全球臨床試驗用品及耗材市場面臨嚴峻挑戰，主要原因是藥物研發階段的高失敗率，這給研發帶來了沉重的經濟負擔。罕見疾病研發的複雜性進一步加劇了這一困境，因為成功進行臨床試驗往往需要專業知識。令人驚訝的是，許多藥物，尤其是在腫瘤領域，在完成臨床試驗後最終未能獲得監管部門的核准。此外，從新藥發現到上市核准的漫長而昂貴的過程也是阻礙市場整體成長和擴張的主要障礙。

全球臨床試驗用品和耗材市場趨勢

由於生物製劑和溫控藥物具有許多治療優勢，例如與傳統治療方法相比副作用較少，全球臨床試驗耗材市場正經歷著向生物製藥和溫控藥物的顯著轉變。生物製藥在後期藥物研發中佔很大比例，大量現有藥物也需要在溫控環境下保存，因此市場預計將對這些趨勢做出積極反應。對低溫運輸物流日益成長的依賴凸顯了供應鏈中基礎設施建設和創新解決方案的必要性，以確保這些敏感產品的完整性和有效性。因此，對低溫運輸設施和先進監測技術的投資激增預計將重塑未來。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
2023-2025年營收年比比較

主要企業簡介

Lonza Group
Catalent, Inc.
Piramal Pharma Solutions
Almac Group
Parexel International
Eurofins Scientific
Marken（A Subsidiary of UPS）
Thermo Fisher Scientific, Inc.
Sharp Services, LLC
PCI Pharma Services
Nuvisan
Celerion
WuXi AppTec
Recipharm AB
Tunnell Consulting
Aesica Pharmaceuticals
Boehringer Ingelheim
Kendle International（Now a part of INC Research）
Syneos Health
Vetter Pharma

結論與建議

簡介目錄

Product Code: SQMIG35B2074

Global Clinical Trial Materials And Supplies Market size was valued at USD 3.84 Billion in 2024 and is poised to grow from USD 4.22 Billion in 2025 to USD 8.91 Billion by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The management of clinical trial supplies is essential to avoid challenges like inventory expiration and overproduction, particularly as the costs of drug detection rise. An efficient supply chain is crucial for navigating the complexities of clinical research while adhering to regulatory demands. The market for clinical trial materials is driven by the increasing number and intricacy of clinical studies. Supplies include various tools vital for medical trials, such as infusion pumps, nebulizers, and syringe needles, used for diagnosing and treating diseases, evaluating therapies, and supporting various medical operations. As drug developers outsource their clinical trial supplies to investigator sites, the market is experiencing accelerated growth, fueled by technological advancements, strategic collaboration among providers, and an uptick in patent expirations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Materials And Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Materials And Supplies Market Segments Analysis

Global Clinical Trial Materials And Supplies Market is segmented by service, phase, type, therapeutic area, end user and region. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labelling & blinding, manufacturing, comparator sourcing and other services. Based on phase, the market is segmented into Phase I, Phase II, Phase III, Phase IV, BA/BE Studies. Based on type, the market is segmented into small-molecules, biologic drugs and medical devices. Based on therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases and other therapeutic areas. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organisations (CRO's) and medical device companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Materials And Supplies Market

The expansion of the Global Clinical Trial Materials and Supplies market is significantly driven by an increase in patient participation in clinical trials in emerging nations such as China, India, and South Korea, where costs are substantially lower compared to developed countries. In these regions, early-phase clinical trials can be considerably less expensive, creating an attractive environment for conducting research, particularly for rare diseases. Furthermore, the advancement of technology and data analytics plays a crucial role in streamlining clinical trial processes, encouraging pharmaceutical and biotechnology companies to outsource innovative solutions. This shift towards developing countries for clinical trials enhances efficiency and encourages collaboration within the industry.

Restraints in the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market faces significant challenges due to the high attrition rates of drug candidates during development, which leads to considerable financial burdens in research and development. The complexity of R&D for rare diseases often requires specialized expertise to successfully conduct clinical trials, further complicating the process. A striking number of drugs, particularly in the field of oncology, fail to secure regulatory approval after reaching clinical testing stages. Furthermore, the lengthy timeline and escalating costs involved in bringing a new drug from discovery to market approval act as major obstacles, hindering the overall growth and expansion of the market.

Market Trends of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is witnessing a notable shift towards biologics and temperature-sensitive medications, driven by their therapeutic advantages, such as lower side effects compared to traditional therapies. With biologics constituting a significant percentage of late-phase pharmaceutical developments and a substantial portion of existing drugs requiring temperature-controlled environments, the market is expected to respond dynamically to these trends. This growing reliance on cold chain logistics underscores the necessity for enhanced infrastructure and innovative solutions in the supply chain to ensure the integrity and efficacy of these sensitive products. As such, investments in cold chain facilities and advanced monitoring technologies are poised to surge, shaping the future landscape of clinical trial materials and supplies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Supply Chain Analysis
Technology Analysis
Regulatory Analysis

Global Clinical Trial Materials And Supplies Market Size by Service & CAGR (2026-2033)

Market Overview
Logistics & Distribution
Storage & Retention
Packaging, Labelling & Blinding
Manufacturing
Comparator Sourcing
Other Services

Global Clinical Trial Materials And Supplies Market Size by Phase & CAGR (2026-2033)

Market Overview
Phase I
Phase II
Phase III
Phase IV
BA/BE Studies

Global Clinical Trial Materials And Supplies Market Size by Type & CAGR (2026-2033)

Market Overview
Small-Molecules
Biologic Drugs
Medical Devices

Global Clinical Trial Materials And Supplies Market Size by Therapeutic Area & CAGR (2026-2033)

Market Overview
Oncology
Infectious Diseases
Neurology
Metabolic Disorders
Immunology
Cardiology
Genetic Diseases
Other Therapeutic Areas

Global Clinical Trial Materials And Supplies Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical And Biotechnology Companies
Contract Research Organisations (CRO's)
Medical Device Companies

Global Clinical Trial Materials And Supplies Market Size & CAGR (2026-2033)

North America (Service, Phase, Type, Therapeutic Area, End User)
- US
- Canada
Europe (Service, Phase, Type, Therapeutic Area, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Service, Phase, Type, Therapeutic Area, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Service, Phase, Type, Therapeutic Area, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Service, Phase, Type, Therapeutic Area, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catalent, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Pharma Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Marken (A Subsidiary of UPS)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Services, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PCI Pharma Services
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvisan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celerion
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Recipharm AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tunnell Consulting
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aesica Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kendle International (Now a part of INC Research)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetter Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments